Amoéba successfully completes the first phase of fundraising

Amoéba, a company specializing in microbiological solutions, has announced the success of the first phase of its fundraising. Through a private placement with qualified investors, it raised €7.9 million via an accelerated book-building process. This transaction will be followed by a capital increase open to all investors, with a target of €10 million.

The funds raised will allow Amoéba to meet its financial needs for the coming year. Furthermore, it plans to monetize its WillaTM cosmetics asset in 2027 to achieve financial independence. In line with its Vision 2030, Amoéba expects revenues of €40 million, with an operating margin of over 10%.